Roy Galvin
Fortuna: 3 M $ al 30/06/2026
Fortuna: 3 M $ al 30/06/2026
Roy Galvin is currently Chief Executive Officer at Cardiva Medical, Inc. Mr. Galvin is also Chief Commercial Officer & Executive VP at Haemonetics Corp., a position starting in 2025.
Formerly, Mr. Galvin was Vice President-Sales at Medtronic Xomed, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HAEMONETICS CORPORATION 0,09 % | 28/05/2026 | 39.467 ( 0,09 % ) | 3 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 01/10/2022 |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
Medtronic Xomed, Inc.
Medtronic Xomed, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes surgical products | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Haemonetics Corp.
Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Medtronic Xomed, Inc.
Medtronic Xomed, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes surgical products | Electronic Technology |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.